Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Renal indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Pre-renal AKI and haemodynamic causes

Renal · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Haemodynamic AKI with shock, active haemorrhage, septic hypoperfusion, myocardial ischaemia, severe heart failure or rapidly progressive pulmonary oedema requires immediate resuscitation and senior critical-care or specialty input; a low urine output must not prompt indiscriminate fluid when the patient is congested.

Overview

Distinguish true intravascular depletion from low effective arterial circulation and venous congestion, restore renal perfusion safely, and prevent haemodynamic AKI from becoming structural injury.

The term pre-renal is useful only if it prompts rapid correction of a reversible fall in filtration. It becomes misleading when treated as synonymous with dehydration. A vomiting patient may need salt and water; a patient with cardiogenic shock can have poor renal perfusion while markedly oedematous; a person with cirrhosis may have total-body fluid excess but severe arterial underfilling. Each requires a different intervention, and all may develop acute tubular injury if the insult persists.

The bedside question is whether cardiac output and arterial pressure are adequate, whether the circulation can respond to additional fluid, and whether venous congestion is opposing renal filtration. Establish the losses and usual weight, assess skin and perfusion alongside JVP and lungs, review the drug combination and seek the primary diagnosis. Dynamic response to passive leg raising or a small, monitored bolus is more informative than static labels when performed correctly.

Management must follow local sepsis, haemorrhage, heart-failure and cirrhosis protocols. Fluid type, blood-product strategy, vasopressor choice and invasive monitoring depend on the underlying condition and care setting; renal physiology should inform those pathways, not replace them.

Aetiology

01

True intravascular volume loss

Haemorrhage, gastrointestinal or renal fluid loss, poor intake and third-space loss reduce circulating volume and renal perfusion.

02

Low effective arterial circulation

Sepsis, cirrhotic vasodilatation and low cardiac output reduce renal driving pressure despite normal or increased total body fluid.

03

Venous congestion

Right-sided heart failure and elevated abdominal or renal venous pressure oppose filtration, producing a haemodynamic AKI that may worsen with indiscriminate fluid.

04

Impaired autoregulation

NSAIDs limit afferent dilatation, ACE inhibitors or ARBs reduce efferent constriction, and diuretics can amplify volume loss during intercurrent illness.

Pathophysiology

  1. 1
    Reduced filtration pressure

    Lower arterial inflow, low cardiac output or elevated venous back-pressure reduces the net pressure driving glomerular filtration.

  2. 2
    Compensatory salt conservation

    Sympathetic, renin–angiotensin and vasopressin responses conserve sodium and water and maintain glomerular tone while perfusion remains recoverable.

  3. 3
    Autoregulatory failure

    Severe hypotension, vascular disease or interfering medicines exceed the kidney's ability to stabilise glomerular flow, causing a rapid fall in filtration.

  4. 4
    Transition to structural injury

    Prolonged oxygen deficit and inflammation damage tubular epithelium, converting a predominantly functional decline into acute tubular injury with slower recovery.

Clinical features and red flags

External volume lossRed flag

Vomiting, diarrhoea, fever, burns, polyuria, poor intake or haemorrhage with weight loss, thirst, postural symptoms, tachycardia and low filling signs favours true depletion. Older adults and people taking beta blockers may lack classic tachycardia.

Septic vasodilatationRed flag

Infection, hypotension, altered mentation, raised lactate or mottled perfusion may indicate distributive shock. Cardiac dysfunction and capillary leak can coexist, so early antibiotics and source control accompany measured haemodynamic support.

Low-output cardiorenal stateRed flag

Raised JVP, oedema, pulmonary congestion, cool peripheries and oliguria suggest cardiac failure with poor forward flow and venous back pressure. Additional crystalloid can worsen renal congestion and gas exchange.

Drug-amplified autoregulatory failure

A recent NSAID, ACE inhibitor or ARB, diuretic increase, or their combination during intercurrent volume loss can precipitate a creatinine rise. This pattern remains a diagnosis of context and does not excuse a search for sepsis, obstruction or intrinsic disease.

Renovascular haemodynamic clue

A marked creatinine rise after renin–angiotensin blockade, flash pulmonary oedema, refractory hypertension or widespread vascular disease raises renal artery stenosis, particularly when both kidneys or a solitary functioning kidney are affected.

Investigations

  1. 01
    Supine and standing observations with perfusion examinationFirst step
    Why
    Identify haemodynamic compromise and quantify response to initial resuscitation.
    Interpretation and limitations
    Postural fall, prolonged capillary refill, cool peripheries or altered mentation support impaired circulation, but no single sign proves fluid responsiveness. Interpret alongside chronic hypertension, medication and autonomic dysfunction.
  2. 02
    Jugular venous pressure, lung assessment and daily weight
    Why
    Detect venous congestion and pulmonary fluid that make routine volume loading hazardous.
    Interpretation and limitations
    Raised JVP, increasing weight, B-lines or crackles and oxygen requirement favour congestion. Peripheral oedema alone is non-specific; combine signs and, where available, focused ultrasound performed by trained staff.
  3. 03
    Serial creatinine, electrolytes, lactate and acid–base profile
    Why
    Measure kidney trajectory, tissue hypoperfusion and treatment consequences.
    Interpretation and limitations
    Improving lactate and perfusion may precede creatinine recovery. Hyperkalaemia can be intensified by renin–angiotensin blockade; high bicarbonate may accompany vomiting, while severe acidosis suggests shock or established renal failure.
  4. 04
    Urinalysis and microscopy
    Why
    Test whether the apparently haemodynamic syndrome has evidence of parenchymal kidney disease.

Differential diagnosis

01

Acute tubular injury

Persistent dysfunction after haemodynamic correction and granular sediment support structural tubular damage, although haemodynamic and tubular mechanisms form a continuum.

02

Post-renal obstruction

Anuria, retention symptoms, bladder distension or collecting-system dilatation indicate impaired outflow rather than impaired perfusion alone.

03

Glomerular or interstitial nephritis

Marked albuminuria, casts, sterile pyuria, rash or systemic immune features favour intrinsic inflammation and should stop repeated empirical fluid challenges.

04

Congestive cardiorenal syndrome

Raised venous pressure, oedema and pulmonary congestion identify a low-filtration state that may need decongestion rather than additional intravascular volume.

Management

01DepletionTreat probable intravascular lossFirst stepA compatible history and examination indicate hypovolaemia without pulmonary or systemic congestion.+
  1. 11. Control ongoing losses, obtain urgent blood tests and cross-match when bleeding is possible, and establish reliable observations and urine measurement.
  2. 22. Give a locally approved isotonic crystalloid bolus, or blood products through the haemorrhage pathway when appropriate, with a pre-specified reassessment time.
  3. 33. Recheck perfusion, pressure, respiratory findings and dynamic response; continue cautiously only when benefit is demonstrated and stop if overload develops.
  4. 44. Replace continuing gastrointestinal or urinary losses thoughtfully, correct electrolytes and review medicines that worsen the current haemodynamic state.
02CongestionManage cardiorenal low flow or venous pressureAKI coexists with raised filling pressure, pulmonary oedema or decompensated cardiac failure.+

Complications

01

Progression to tubular injury

Sustained hypoperfusion causes epithelial ischaemia, granular casts and prolonged renal dysfunction after the initial circulation problem is corrected.

02

Electrolyte and acid-base disturbance

Progressive filtration loss and the precipitating illness can cause hyperkalaemia, metabolic acidosis and uraemia with cardiac or neurological consequences.

03

Iatrogenic pulmonary oedema

Repeated fluid administration without reassessment can worsen venous congestion and gas exchange, particularly when low cardiac output rather than depletion drives AKI.

04

Multiorgan hypoperfusion

Severe haemorrhage, shock or low output can simultaneously injure brain, myocardium, liver and gut, reducing renal recovery and overall survival.

Monitoring and follow-up

  • Reassess blood pressure, mental state, capillary refill, peripheral temperature and lactate after each intervention; a prescription without a response endpoint is incomplete.
  • Measure urine output and cumulative balance, but do not use a transient diuresis as the sole proof that tissue perfusion is adequate.
  • Track JVP, lung signs, oxygen need and weight so emerging venous congestion is recognised before repeated fluid produces respiratory failure.
  • Repeat creatinine, potassium, sodium, bicarbonate and magnesium according to severity, and increase frequency after diuresis, large losses or vasoactive treatment.
  • Maintain a visible medicines plan covering temporary holds, renal dose adjustment and timely restart of ACE inhibitor, ARB, mineralocorticoid antagonist, diuretic or diabetes treatment when indicated.

Special situations

Congestion can reduce filtration

Renal perfusion is not simply arterial pressure. Raised renal venous pressure lowers the filtration gradient, which explains why carefully achieved decongestion can improve a cardiorenal state even when creatinine initially fluctuates.

Responsiveness is transient information

Passive leg raising predicts whether stroke volume may rise with volume at that moment. It does not establish dehydration, guarantee kidney recovery or authorise repeated litres without further review.

Urinary indices have context limits

Low urinary sodium can occur in heart failure and early glomerular disease, while diuretics can raise it. Fractional indices are supporting observations, not a substitute for the illness timeline and sediment.

ACE inhibitor rise is a clue

A creatinine increase after renin–angiotensin blockade may reflect expected haemodynamic change, intercurrent depletion or clinically important bilateral renovascular disease. The magnitude, potassium and clinical setting determine the response.

Sepsis crosses categories

A septic patient can progress from vasodilatory hypoperfusion to inflammatory tubular damage while also becoming fluid overloaded. Repeated reassessment is more accurate than preserving an early pre-renal label.

Common pitfalls

  1. 01

    Equating peripheral oedema with adequate renal perfusion ignores low effective arterial volume and, conversely, using oedema as a reason to overlook intravascular depletion can delay resuscitation.

  2. 02

    Using a urea-to-creatinine ratio or fractional excretion threshold as a binary diagnostic test produces errors in sepsis, CKD, catabolism and diuretic treatment.

  3. 03

    Continuing to administer crystalloid after pressure, perfusion or stroke volume has stopped responding exposes the patient to dilution and lung oedema without renal benefit.

  4. 04

    Describing every creatinine rise during decongestion as worsening kidney failure may lead to premature withdrawal of effective heart-failure treatment despite persistent congestion.

  5. 05

    Failing to restart evidence-based cardiovascular medicines after a temporary illness-related hold turns a sensible acute precaution into chronic undertreatment.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
RenalOriginal SBA

Congested oliguric patient

A patient with decompensated heart failure has oliguria, a raised jugular venous pressure, basal crackles, peripheral oedema and increasing oxygen requirement. Which initial renal strategy is most appropriate?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Renal topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG148 acute kidney injury recommendationsAssessment of causes, volume status, medicines and escalation.
  • Think Kidneys medicines optimisation for AKINHS professional guidance on medication review during AKI.
  • UK Kidney Association acute kidney injury guidelineProfessional AKI prevention and management recommendations.
  • NHS acute kidney injury informationPatient-facing causes and treatment overview maintained by the NHS.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

Key points

  • Pre-renal AKI reflects reduced glomerular filtration from impaired perfusion without necessarily implying whole-body dehydration; haemorrhage, sepsis, low cardiac output and cirrhotic vasodilatation can produce different haemodynamic phenotypes.
  • Effective filtration depends on systemic pressure, renal blood flow and glomerular arteriolar tone. NSAIDs impair prostaglandin-mediated afferent dilatation, while ACE inhibitors and ARBs reduce angiotensin-mediated efferent constriction.
  • Diuretics can compound salt and water loss, creating the familiar ACE inhibitor or ARB plus diuretic plus NSAID risk combination, particularly during intercurrent illness.
  • Examine for both depletion and congestion: mucosa, capillary refill, postural symptoms, jugular venous pressure, oedema, lung crackles, weight change, perfusion, bedside echo and passive-leg-raise response where expertise exists.
  • A single fluid challenge should have a stated indication, amount and reassessment endpoint. Failure to improve should trigger diagnostic revision rather than serial unrecorded boluses.
  • Sepsis-associated AKI is not purely ‘pre-renal’; inflammation, microcirculatory dysfunction and tubular injury may coexist, so treat infection and haemodynamics while avoiding false certainty from urinary indices.
  • Fractional excretion of sodium and urea can be distorted by diuretics, CKD, sepsis and timing. They may support a carefully framed assessment but should not overrule examination, urine sediment and trajectory.
Interpretation and limitations
A bland sediment is compatible with reduced perfusion but is not definitive. Granular casts suggest tubular injury, while blood with significant protein or cellular casts should redirect the pathway toward glomerular or interstitial disease.
  • 05
    Passive leg raise or monitored small fluid challenge
    Why
    Assess dynamic fluid responsiveness when examination leaves uncertainty and extra volume might help or harm.
    Interpretation and limitations
    A transient increase in stroke volume or validated surrogate supports responsiveness, not an unlimited fluid prescription. Stop if congestion or oxygenation worsens, and investigate low output or vasodilatation if no beneficial response occurs.
  • 06
    Source-directed imaging and cultures
    Why
    Find haemorrhage, infection, cardiac dysfunction or another precipitant that requires definitive treatment.
    Interpretation and limitations
    Cultures, chest imaging, abdominal imaging, echocardiography or bleeding studies should answer a defined clinical question. Necessary emergency imaging must not be withheld solely because AKI is present.
    1. 11. Assess severity with ECG, oxygenation, congestion findings and cardiac evaluation, and involve acute medicine or cardiology early when shock or pulmonary oedema is present.
    2. 22. Avoid reflex crystalloid; treat the cardiac precipitant and use diuresis, vasodilator or inotropic/vasopressor support only through the appropriate monitored protocol.
    3. 33. Follow symptoms, weight, urine sodium where locally used, urine output, creatinine and electrolytes; a modest creatinine change during effective decongestion may not mean treatment failure.
    4. 4Escalation4. Escalate for refractory overload, worsening perfusion or dialysis-level complications, balancing renal recovery against the immediate respiratory and circulatory threat.
    03MedicationMake reversible drug decisions safelyAKI occurs during ACE inhibitor, ARB, NSAID, diuretic or other pressure-altering treatment.+
    1. 11. List indication, last dose, recent changes and concurrent illness; stop non-essential NSAIDs and identify combinations that impair renal autoregulation or volume status.
    2. 22. Temporarily hold selected agents only when hypotension, hypovolaemia, hyperkalaemia or accumulation risk justifies it, documenting the clinical reason.
    3. 33. Treat the precipitating illness and repeat renal function and potassium after stabilisation rather than waiting indefinitely for a perfect creatinine.
    4. 44. Before discharge, assign a date and clinician to reassess and restart prognostic heart-failure, kidney or blood-pressure therapy when safe.
    Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
    Corrects genuine extracellular and intravascular depletion while definitive control of losses, sepsis or haemorrhage is arranged.

    Isotonic crystalloid resuscitation

    Use a protocol-sized bolus for suspected hypovolaemia and reassess after each administration; frailty, cardiac failure and renal congestion usually require smaller increments and closer observation.

    Do not prescribe an open-ended volume or chase urine output without benefit. Excess chloride, sodium and water can worsen acidosis, oedema and pulmonary congestion; follow the current local intravenous-fluid policy.

    Supports vascular tone in vasodilatory shock when fluids alone cannot restore adequate perfusion pressure.

    Noradrenaline through a critical-care protocol

    Titrate by trained critical-care staff to an individual haemodynamic target after appropriate initial volume assessment; concentration, access and rate follow the local vasoactive infusion policy.

    This is not a ward treatment for isolated creatinine rise. It requires monitored vascular access, continuous observations and treatment of the underlying infection or shock; excessive vasoconstriction and extravasation can cause harm.

  • Temporarily withholding a haemodynamically active medicine can be appropriate during hypotension or volume loss, but its indication must be revisited promptly once perfusion, potassium and renal function stabilise.